• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHS1800030 赞布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2018-10-24 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd Certificate Issued 2020-06-10 view
CXHS1800024 赞布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2018-08-29 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd Certificate Issued 2020-06-10 view
CXHB2400082 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2024-04-09 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2100005 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2021-01-09 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2021-01-08 view
CXHL2101615 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2021-10-27 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2300432 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2023-04-25 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2000142 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-04-09 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-04-08 view
CXHB2100057 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2021-04-10 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2022-01-27 view
CXHB2101135 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2021-10-28 BeiGene (Beijing) Co Ltd view
CXHL1900248 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2019-08-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2019-08-19 view
CXHS2200007 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2022-01-28 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2300047 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2023-03-02 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2000143 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-04-09 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-04-08 view
CXHB2101014 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2021-04-23 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CYHB2200296 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2022-02-10 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2400070 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2024-03-21 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2000611 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-12-02 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-12-01 view
CYHB2200307 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2022-02-11 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2000019 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs Supplementary Application 2020-03-24 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-03-23 view
CXHB2200027 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2022-03-03 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view